Psilocybin for Major Depressive Disorder (MDD)

NCT06308653 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

238

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Psilocybin 25 mg
DRUG: Inactive Placebo
DRUG: Psilocybin 5 mg
BEHAVIORAL: Psychosocial Support

Sponsor

Usona Institute